Analysts: Catalyst Pharmaceutical Partners Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

3.91USD
26 Mar 2015
Change (% chg)

-- (--)
Prev Close
$3.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
183,009
52-wk High
$5.10
52-wk Low
$1.70

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 27 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 5 5 4 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 3 0.00 0.00 0.00 0.00
Quarter Ending Jun-15 3 0.00 0.00 0.00 0.00
Year Ending Dec-15 3 0.00 0.00 0.00 0.00
Year Ending Dec-16 3 14.00 22.73 5.00 10.48
Earnings (per share)
Quarter Ending Mar-15 3 -0.09 -0.06 -0.12 -0.07
Quarter Ending Jun-15 3 -0.09 -0.05 -0.12 -0.07
Year Ending Dec-15 3 -0.41 -0.22 -0.50 -0.24
Year Ending Dec-16 3 -0.25 -0.21 -0.30 -0.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 0.00 0.00 0.00 0.00
Quarter Ending Sep-14 0.00 0.00 0.00 0.00
Quarter Ending Jun-14 0.00 0.00 0.00 0.00
Quarter Ending Mar-14 0.00 0.00 0.00 0.00
Quarter Ending Dec-13 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 0.00 0.00 0.00 0.00 0.00
Quarter Ending Jun-15 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-15 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-16 14.00 14.00 16.26 17.61 10.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 0
Year Ending Dec-16 0 0 1 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks